Patent holdings for IPC class A61K 31/40

Total number of patents in this class: 5279

10-year publication summary

332
350
349
378
338
383
371
335
318
70
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

Principal owners for this class

Owner
All patents
This class
The Regents of the University of California
18943
70
Novartis AG
11238
63
Chiesi Farmaceutici S.p.A.
940
63
F. Hoffmann-La Roche AG
7958
52
Daiichi Sankyo Company, Limited
1829
46
Takeda Pharmaceutical Company Limited
2961
44
Amarin Pharmaceuticals Ireland Limited
267
44
Bristol-myers Squibb Company
5080
37
Allergan, Inc.
2600
34
Bodor Laboratories, Inc.
59
33
Boehringer Ingelheim International GmbH
4629
32
Merck Sharp & Dohme Corp.
2247
30
Theravance Biopharma R&D IP, LLC
550
27
Merck Sharp & Dohme LLC
3689
27
Hoffmann-La Roche Inc.
3060
26
Sanofi
3836
26
Pfizer Inc.
3322
25
Duke University
2872
25
Sunovion Pharmaceuticals Inc.
326
25
The Scripps Research Institute
1364
24
Other owners 4526